Core Viewpoint - The strategic cooperation between Fosun Pharma and Ruizhi Pharma aims to enhance drug development efficiency and quality, thereby solidifying Fosun Pharma's competitive advantage in the innovative pharmaceutical sector [1] Company Summary - Fosun Pharma's Senior Vice President and CEO of Global R&D Center, Li Xiang, highlighted the potential for improved efficiency and quality in drug development through collaboration with Ruizhi Pharma [1] - The partnership is expected to accelerate the transformation of innovative results into practical applications, reinforcing Fosun Pharma's position in the innovative medicine field [1] Industry Summary - The collaboration sets a benchmark for the industry by exemplifying a model of "innovation entity + service platform," which is anticipated to facilitate efficient integration of resources across the pharmaceutical supply chain [1] - This partnership aims to elevate the overall level of new drug development in China, ultimately providing more high-quality treatment options for patients [1]